Weighted Average Number of Shares Outstanding, Diluted of VERACYTE, INC. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
VERACYTE, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2019 to Q3 2025.
  • VERACYTE, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 79,691,703, a 1.6% increase year-over-year.
  • VERACYTE, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 78,163,217, a 7.6% increase from 2023.
  • VERACYTE, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 72,644,487, a 1.5% increase from 2022.
  • VERACYTE, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 71,549,204, a 5.4% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

VERACYTE, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 79,691,703 +1,227,049 +1.6% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 78,391,502 +1,228,353 +1.6% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 80,056,024 +5,296,235 +7.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 78,163,217 +5,518,730 +7.6% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
Q3 2024 78,464,654 +5,659,884 +7.8% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 77,163,149 +4,684,487 +6.5% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 74,759,789 +2,584,332 +3.6% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 72,644,487 +1,095,283 +1.5% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 72,804,770 +1,148,076 +1.6% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 72,478,662 +1,001,696 +1.4% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 72,175,457 +945,785 +1.3% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 71,549,204 +3,658,876 +5.4% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 71,656,694 +1,912,961 +2.7% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 71,476,966 +4,160,901 +6.2% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q1
Q1 2022 71,229,672 +7,897,970 +12% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 67,890,328 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 69,743,733 +14,885,681 +27% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 67,316,065 +17,103,942 +34% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 63,331,702 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q3 2020 54,858,052 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 50,212,123 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2

VERACYTE, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 78,163,217 +5,518,730 +7.6% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025 2024 FY
2023 72,644,487 +1,095,283 +1.5% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
2022 71,549,204 +3,658,876 +5.4% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 67,890,328 +14,651,097 +28% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 53,239,231 +7,101,054 +15% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 46,138,177 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.